Bottom line
What does KURE hold?
KURE held 63 positions as of Jun 30, 2026. Its largest holding is BeOne Medicines AG at 8.84% of the fund, and the top 10 positions add up to 54.1%. By asset type it is 100% stocks, 4% cash & short-term funds.
Updated Aug 28, 2026
KURE top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | BeOne Medicines AG BEONE MEDICINES LTD-H COMMON STOCK |
Stocks | 8.84% | $6.3M |
| 2 | Innovent Biologics, Inc. INNOVENT BIOLOGICS INC COMMON STOCK |
Stocks | 8.80% | $6.3M |
| 3 | Wuxi Biologics (cayman) Inc. WUXI BIOLOGICS CAYMAN INC COMMON STOCK |
Stocks | 7.51% | $5.4M |
| 4 | WuXi AppTec Co., Ltd. WUXI APPTEC CO LTD-A COMMON STOCK |
Stocks | 5.79% | $4.1M |
| 5 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd JIANGSU HENGRUI PHARMACEUT-A COMMON STOCK |
Stocks | 4.59% | $3.3M |
| 6 | Shenzhen Mindray Bio-Medical Electronics Co Ltd SHENZHEN MINDRAY BIO-MEDIC-A COMMON STOCK |
Stocks | 4.27% | $3.0M |
| 7 | Akeso Inc AKESO INC COMMON STOCK |
Stocks | 3.72% | $2.6M |
| 8 | Cspc Pharmaceutical Group Limited CSPC PHARMACEUTICAL GROUP LT COMMON STOCK |
Stocks | 3.68% | $2.6M |
| 9 | Invesco Government & Agency Portfolio | Cash & short-term funds | 3.55% | $2.5M |
| 10 | Sino Biopharmaceutical Limited SINO BIOPHARMACEUTICAL COMMON STOCK |
Stocks | 3.39% | $2.4M |
| 11 | WuXi AppTec Co., Ltd. WUXI APPTEC CO LTD-H COMMON STOCK |
Stocks | 3.35% | $2.4M |
| 12 | Hansoh Pharmaceutical Group Company Limited HANSOH PHARMACEUTICAL GROUP COMMON STOCK |
Stocks | 2.85% | $2.0M |
| 13 | 3SBio Inc. 3SBIO INC COMMON STOCK |
Stocks | 2.49% | $1.8M |
| 14 | Yunnan Baiyao Group Co., Ltd YUNNAN BAIYAO GROUP CO LTD-A COMMON STOCK |
Stocks | 2.30% | $1.6M |
| 15 | Shanghai United Imaging Healthcare Co., Ltd. SHANGHAI UNITED IMAGING HE-A COMMON STOCK |
Stocks | 2.27% | $1.6M |
| 16 | Aier Eye Hospital Group Co., Ltd. AIER EYE HOSPITAL GROUP CO-A COMMON STOCK |
Stocks | 2.10% | $1.5M |
| 17 | Sichuan Biokin Pharmaceutical Co Ltd SICHUAN BIOKIN PHARMACEUTI-A COMMON STOCK |
Stocks | 1.97% | $1.4M |
| 18 | Sichuan Kelun-Biotech Biopharmaceutical Co Ltd SICHUAN KELUN-BIOTECH BIOP-H COMMON STOCK |
Stocks | 1.85% | $1.3M |
| 19 | Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. ZHANGZHOU PIENTZEHUANG PHA-A COMMON STOCK |
Stocks | 1.73% | $1.2M |
| 20 | Sinopharm Group Co. Ltd. SINOPHARM GROUP CO-H COMMON STOCK |
Stocks | 1.67% | $1.2M |
| 21 | Sichuan Kelun Pharmaceutical Co., Ltd. SICHUAN KELUN PHARMACEUTIC-A COMMON STOCK |
Stocks | 1.55% | $1.1M |
| 22 | Haisco Pharmaceutical Group Co., Ltd. HAISCO PHARMACEUTICAL GROU-A COMMON STOCK |
Stocks | 1.53% | $1.1M |
| 23 | Huadong Medicine Co., Ltd HUADONG MEDICINE CO LTD-A COMMON STOCK |
Stocks | 1.36% | $969.1K |
| 24 | WuXi XDC Cayman Inc WUXI XDC CAYMAN INC COMMON STOCK |
Stocks | 1.35% | $963.9K |
| 25 | Shanghai Allist Pharmaceuticals Co Ltd SHANGHAI ALLIST PHARMACEUT-A COMMON STOCK |
Stocks | 1.34% | $954.4K |
Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 28, 2026